Review on t(11;14)(p13;q32), with data on clinics, and the genes involved.
Clinics and pathology
Disease Mature B-cell non-Hodgkin Lymphomas (NHL) . Nine cases available so far, from a unique study (Hu et al., 2010) .
Phenotype/cell stem origin
In a study of 114 cases of mature B-cell NHLs, the t(11;14)(p13;q32) IGH/CD44 was found in: -4 cases (8%) of gastric lymphoma; mucosaassociated lymphoid lymphoma (MALT): 1 (25%); composite DLBCL with residual MALT lymphoma: 2 (33%); diffuse large B-cell lymphoma (DLBCL) germinal center B-cell-like (GCB)-type: 1 (4%); -2 cases (25%) of non-gastric extranodal lymphoma: DLBCL GCB-type: 2 (67%); -2 cases (7%) of follicular lymphoma (FL), one of which also harboring a t(14;18)(q32;q21) IGH/BCL2; -1 cases (4%) of nodal DLBCL GCB-type.
Genes involved and proteins CD44
Location 11p13 DNA/RNA 20 exons spanning 60 kb. The first five and the last five exons are constant; while the ten exons located between, are subject to alternative splicing, resulting in the generation of CD44 variants. Protein CD44 is composed of extracellular, transmembrane, and cytoplasmic domains. CD44 is a membrane receptor which plays a role in cell adhesion (cell-cell and cell-extracellular matrix interactions), cell traffic, presentation of chemokines and growth factors, signals transmission. High levels of expression of CD44 have been observed in a high number of cancer types, including non-Hodgkin Lymphomas (Sen and Yip 2010) .
IGH Location 14q32.33

Result of the chromosomal anomaly
Hybrid gene
Description 5' IGH-3' CD44.
The translocation juxtaposes the IGHSμ enhancer to the 5' regulatory region of CD44 in a tail-to-head orientation. Various breakpoints: breakpoints were spread within small regions of IGHSμ and small regions between CD44 exon 1 and 2. 
Fusion protein
Description CD44 starting from the ATG at nucleotide 254 with a strong Kozak sequence.
Oncogenesis
The ectopic expression of CD44 resulted in increase in cell growth and clonogenicity. To be noted is that the t(11;14)(p13;q32) was detected in 4 patients with advanced stages of disease.
